DULOSIGN 30 CAP by Dr Precision is a specialized pharmaceutical formulation containing 30 mg of Duloxetine Hydrochloride, a selective serotonin and norepinephrine reuptake inhibitor (SSNRI). This capsule is specifically designed for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Manufactured by BluepillExpress in WHO-GMP and ISO 9001:2015 certified facilities, DULOSIGN 30 ensures high-quality standards meeting international regulatory requirements for global markets including Africa, Asia, Latin America, CIS, and the Middle East. Its dual mechanism blocks the reuptake of serotonin and norepinephrine neurotransmitters, enhancing mood regulation and providing analgesic effects in neuropathic and chronic pain conditions. Thanks to its consistent efficacy and patient safety profile, DULOSIGN 30 CAP is an optimal pharmaceutical choice for healthcare providers addressing complex psychiatric and neurological disorders.
Key Features
| Features | Description |
|---|---|
| Generic Name | Duloxetine Hydrochloride |
| Strength | 30 mg per capsule |
| Pharmacological Class | Selective Serotonin and Norepinephrine Reuptake Inhibitor (SSNRI) |
| Therapeutic Uses | Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathic Pain, Fibromyalgia, Chronic Musculoskeletal Pain |
| Dosage Form | Hard Gelatin Capsule for Oral Administration |
| Manufacturing Compliance | WHO-GMP, ISO 9001:2015 certified |
| Export Availability | Global - Africa, Asia, Latin America, CIS, Middle East |
| Mechanism of Action | Inhibits serotonin and norepinephrine reuptake, improving mood and reducing pain signaling |
| Product Label | Dr Precision |
| Manufactured by | BluepillExpress |
| Attributes | Description |
|---|---|
| Active Ingredient | Duloxetine Hydrochloride |
| Dosage Strength | 30 mg |
| Capsule Type | Hard Gelatin Capsule |
| Pharmacological Category | SSNRI Antidepressant and Analgesic |
| Indications | MDD, GAD, Diabetic Neuropathic Pain, Fibromyalgia, Chronic Pain Syndromes |
| Shelf Life | 24 months from manufacturing date |
| Packaging | Blister Packs or Bottles, customizable for bulk orders |
| Regulatory Approval | WHO-GMP, ISO 9001:2015 compliant facility |
| Storage Condition | Store below 25°C, protect from moisture and light |
| Country of Manufacture | Manufactured in BluepillExpress WHO-GMP certified facility |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, DULOSIGN 30 is manufactured in WHO-GMP certified facilities compliant with international quality standards, making it ideal for hospital tenders and regulated market submissions.
Absolutely, it specifically contains Duloxetine Hydrochloride 30 mg which is clinically approved and effective for managing diabetic peripheral neuropathic pain.
Unlike traditional anti-inflammatory or opioid analgesics, DULOSIGN 30 works centrally by modulating serotonin and norepinephrine levels to reduce pain sensitivity and improve mood simultaneously.
Yes, thanks to its manufacturing under WHO-GMP and ISO standards, it is designed for wide export availability including Africa, Asia, Latin America, CIS, and the Middle East.
Manufactured by BluepillExpress under strict GMP guidelines, DULOSIGN 30 ensures batch-to-batch consistency and patient safety adhering to rigorous quality control.
Yes, DULOSIGN 30 is effective and indicated for fibromyalgia, providing pain relief and improving overall neurological function.
It is manufactured in WHO-GMP and ISO 9001:2015 certified facilities ensuring adherence to global pharmaceutical quality standards.
Country Of Origin: India
DULOSIGN 30 Capsule contains Duloxetine Hydrochloride 30 mg, a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) used to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Manufactured under stringent WHO-GMP-certified conditions by BluepillExpress, this product ensures global therapeutic compliance with consistent efficacy and patient safety across regulated and semi-regulated markets.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
DULOSIGN 30 Capsule is a high-quality pharmaceutical formulation containing Duloxetine Hydrochloride 30 mg, a centrally acting dual reuptake inhibitor of serotonin and norepinephrine (SSNRI). This innovative molecule is widely used in the management of depression, anxiety, neuropathic pain, fibromyalgia, and chronic pain disorders, making it a versatile choice in both psychiatric and neurological settings.
As a centrally active antidepressant and analgesic, DULOSIGN 30 modulates pain perception and mood by increasing levels of key neurotransmitters in the brain, namely serotonin and norepinephrine, both of which are typically deficient in conditions like major depressive disorder (MDD) and chronic pain syndromes.
DULOSIGN 30 is formulated and manufactured by BluepillExpress, a global leader in third-party pharmaceutical manufacturing and exports. Produced in WHO-GMP and ISO-certified facilities, the product is tailored to meet international quality benchmarks for regulatory submissions, hospital tenders, and global brand expansion. With proven efficacy and a favorable safety profile, DULOSIGN 30 is a suitable choice for prescribers and patients alike.
✅ Key Features & Benefits
Generic Name: Duloxetine Hydrochloride
Strength: 30 mg per capsule
Pharmacological Class: SSNRI (Serotonin-Norepinephrine Reuptake Inhibitor)
Therapeutic Use: Antidepressant, Anxiolytic, Neuropathic pain management
Dosage Form: Hard gelatin capsule for oral administration
Manufacturing Compliance: WHO-GMP, ISO 9001:2015
Export Availability: Worldwide (Africa, Asia, Latin America, CIS, Middle East)
✅ Mechanism of Action
Duloxetine works by inhibiting the reuptake of serotonin and norepinephrine at the synaptic cleft, thereby increasing their levels in the central nervous system. This dual-action mechanism:
Improves mood and emotional balance in depression and anxiety
Reduces central sensitization and pain transmission in chronic neuropathic pain conditions
Provides analgesic effects independent of traditional anti-inflammatory or opioid pathways
✅ Clinical Indications
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder (GAD)
Diabetic Peripheral Neuropathic Pain
Fibromyalgia
Chronic Lower Back Pain
Osteoarthritis-Related Pain
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze